Business, energy, technology, markets and global industry news from Business News Today

generic semaglutide

PharmaDeviceNews generic semaglutide
Pharma & Biotech

Phoenix and Raven launch direct-to-patient generic semaglutide after Health Canada approval

Generic semaglutide is cheaper, but access is now the real battleground. Phoenix and Raven are testing Canada’s GLP-1 telehealth future.

Read More
Representative image: Generic semaglutide injection pens on a clinical desk with Canadian healthcare cues, reflecting Dr. Reddy’s Laboratories’ launch of generic semaglutide injection in Canada and the growing focus on GLP-1 access for type 2 diabetes treatment.
Pharma & Biotech

Dr. Reddy’s moves first in Canada’s generic semaglutide market. Can access improve?

GLP-1 demand is booming, but access remains uneven. Dr. Reddy’s Canada launch tests whether generics can change semaglutide economics.

Read More
Pharma & Biotech

Can Apotex crack the complex generic code for semaglutide before the glucagon-like peptide-1 market resets?

Apotex won first tentative U.S. approval for generic semaglutide. Read what it could mean for glucagon-like peptide-1 access, pricing, and competition.

Read More